Developers: | Stereotaxis |
Date of the premiere of the system: | November 2024 |
Branches: | Pharmaceuticals, Medicine, Healthcare |
Technology: | Robotics |
Content |
History
2024: Product Yield
On November 6, 2024, the company Stereotaxis announced the start of operation of its robotic Genesis magnetic navigation platform (RMN). It began to be used by doctors health care at the University of Kansas System. treatment arrhythmias
It is noted that tens of millions of people around the world suffer from arrhythmia. This is a violation of cardiac conduction, in which there is a change in the frequency, rhythm and regularity of contractions of the heart muscle. The heart can beat too quickly, too slowly, or irregularly. Left untreated, arrhythmia can significantly increase the risk of stroke, heart failure and sudden cardiac arrest. The Genesis RMN platform provides high accuracy and safety in the use of ablation for the therapy of arrhythmias.
The Genesis RMN uses new smaller magnets that rotate around their center of mass. They are located on flexible and strong robotic manipulators, which significantly increases the range of movement. The system provides an instant response to the surgeon's actions, thereby achieving high efficiency. In addition, thanks to the relatively small dimensions of the Genesis RMN, access to the patient during the procedure is facilitated and free space in the operating room is increased.
Genesis is a leap forward in robotic magnetic navigation technology, representing the future of robotics in electrophysiology. We completely redesigned the magnets and the way they were used, giving doctors and hospitals more options, says Stereotaxis. |
The robotic accuracy and stability offered by the Genesis system allows surgeons to perform personalized procedures, which ultimately improves intervention outcomes and improves the quality of life of people with arrhythmia.[1]